Oxford Global, London, United Kingdom
18-19 May 2016
Day 1 – Development And Formulation Of Inhaled Therapies · Combination product design · Achieving an inhaled insulin product · Developing a generic inhaled product · Regulatory considerations for inhaled therapies · Alternative therapeutic fields: inhaled antibiotics · Future directions in inhalation and respiratory drug delivery research Day 2 – Inhalation Devices And Analytics · Novel technologies for pulmonary and nasal delivery · The challenge of developing inhalation devices o Dry-powder inhalers (DPIs) o Metered-dose inhalers (MDIs) o Nebulisers · Improving patient adherence with product design · Establishing clear relationships between in vitro and in vivo data · Analytical tools for inhaled medicines
|